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Abstract
Class II fusion proteins encoded by tick-borne encephalitis virus (TBEV), dengue virus, and Semliki Forest virus have a fusion peptide
located at the end of a rod-like molecule comprised of three antiparallel  sheet domains. Proteomics computational analyses suggest that
hepatitis C virus (HCV) envelope glycoprotein E1 and pestivirus envelope glycoprotein E2 are truncated class II fusion proteins. Similarities
were also detected between the receptor-binding portion of TBEV E and HCV E2, and between TBEV small membrane protein precursor
prM and pestivirus E1. The proposed models of Flaviviridae envelope proteins can facilitate drug and vaccine development.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Entry of enveloped animal viruses requires fusion between
the viral membrane and a cellular membrane, either the plasma
membrane or an internal membrane. Class I fusion proteins
possess a “fusion peptide” at or near the amino terminus, a pair
of extended  helices and, generally, a cluster of aromatic
amino acids proximal to a hydrophobic transmembrane an-
choring domain (Carr and Kim, 1993; Suarez et al., 2000;
Wilson et al., 1981). Several otherwise disparate viruses, in-
cluding orthomyxoviruses, paramyxoviruses, retroviruses,
arenaviruses, and filoviruses, encode class I fusion proteins
varying in length and sequence, but highly similar in overall
structure (Gallaher, 1996; Gallaher et al., 1989). X-ray crys-
tallography of the E glycoprotein of tick-borne encephalitis
virus (TBEV), a member of the genus flavivirus of the Flavi-
viridae family, revealed a structure for this fusion protein
distinct from other fusion proteins (Rey et al., 1995). E pos-
sesses an internal fusion peptide stabilized by dicysteine link-
ages and three domains (I–III) comprised mostly of antiparallel
 sheets. In the slightly curved rod-like configuration of the E
protein present in the virion, the fusion peptide is located at the
tip of domain II, the furthest point distal from the C-terminal
transmembrane anchor. Examination by Lescar et al. (2001) of
E1, the fusion protein of the Togavirus Semliki Forest virus
(SFV), revealed a remarkable fit to the scaffold of TBEV E.
Recently, E of dengue virus, a medically important flavivirus,
was also shown to have a class II structure (Kuhn et al., 2002).
Based on sequence similarities, it is likely that the E glyco-
proteins of other members of the flavivirus genus within the
family Flaviviridae, including West Nile virus, are also class II
fusion proteins. Proteomics computational analyses presented
here suggest that glycoproteins of viruses from members of the
other two genuses of the Flaviviridae family, hepaciviruses and
pestiviruses, have differently truncated class II fusion protein
structures.
Results
Proteomics computational analyses suggest that hepatitis
C virus E1 is a truncated class II fusion protein
The Flaviviridae family consists of three genuses, flavi-
viruses, hepaciviruses and pestiviruses. Hepatitis C virus,
the only member of the hepacivirus genus, encodes two
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envelope glycoproteins, E1 (gp35) and E2 (gp70), both with
C-terminal transmembrane anchor domains. Yagnik et al.
(2000) used proteomics computational analysis tools to pro-
duce a model of HCV E2 templated on the known structure
of TBEV E. All known neutralization antibody binding
epitopes could be placed at surface locations in the proposed
model. Lescar et al. (2001) stated that their structural de-
terminations of SFV E1, which established the existence of
a second class of fusion proteins, “indeed support the pro-
posed model of the hepatitis C virus envelope protein E2
which was based on the 3D structure of the flavivirus
envelope protein E.” However, Flint et al. (1999) provided
strong evidence that the E1 glycoprotein contains the fusion
peptide of HCV. Therefore, we considered the possibility
that E1, in addition to or rather than E2, might have a class
II fusion protein structure.
Previous studies have successfully used a “Rosetta
Stone” strategy employing the fusion peptide and other
identifiable features in combination with computer algo-
rithms that predict secondary structure to construct useful
working models of viral envelope proteins. Gallaher and
coworkers’ model of the retroviral transmembrane glycop-
rotein (TM) (Gallaher et al., 1989) was based on the known
structure of HA2, the prototypic class I fusion protein (Wil-
son et al., 1981). Later, Gallaher (1996) fit the fusion protein
of Ebola virus, a filovirus, to retroviral TM. Both models
proved remarkably similar to the structures eventually
solved by X-ray crystallography (Chan et al., 1997; Malash-
kevich et al., 1999; Weissenhorn et al., 1998; Weissenhorn
et al., 1996).
A similar approach, supplemented with newer proteom-
ics computational tools, was applied to HCV E1, which we
modeled to fit the scaffold of TBEV E, the prototypic class
II fusion protein. Because HCV E1 is shorter than TBEV E,
we reasoned that the former might contain several “dele-
tions” relative to the latter. The HCV E1 fusion peptide
(Flint et al., 1999) was assumed to be located at the end of
the molecule farthest from the carboxyl terminal (C-termi-
nal) transmembrane anchor domain, and, like other class II
fusion proteins, to be comprised mostly of antiparallel 
sheets. This latter assumption was supported by Chou-Fas-
man (Chou and Fasman, 1974) and Robson-Garnier (Biou
et al., 1988) analyses, the most commonly applied second-
ary structure prediction algorithms. (Chou-Fasman and
Robson-Garnier analyses of TBEV E and HCV E1 are
posted as supplemental material on All the Virology on
the World Wide Web; http://www.virology.net)
To begin the comparison, the putative fusion peptide of
HCV (amino acids [aa] 272 to 281 of the full-length
polyprotein) was aligned with the fusion peptide of TBEV E
(aa 385–396) (Fig. 1A). Both TBEV E and HCV E1 fusion
peptides have cysteine residues at either end and contain a
core of mostly aromatic and hydrophobic aa (Fig. 1A, red).
Another domain readily identifiable in HCV E1 is the trans-
membrane domain. Amino acids 361 to 381 of the hydro-
phobic sequence near the carboxyl terminus of E1 were
predicted to form a transmembrane helix by TMpred
(TMpred score 1308, 500 is statistically significant).
The sequence similarities between TBEV E and HCV E1
do not permit overall alignment by computational methods
alone. However, several regions of predicted  sheets and 
helices in HCV E1 showed similarities to sequences known
to assume those secondary structures in TBEV E (Fig. 1A).
Beginning from the amino terminus, the first similarity of
HCV E1 begins in  sheet Do of TBEV E and extends
through the fusion peptide. PRSS3, a sequence alignment
algorithm, was used to confirm that there is a significant
similarity (P  0.025) between aa 246–281 of HCV E1 and
aa 350–396 of TBEV E (Fig. 1B). The fusion peptide is
flanked by  sheets in class II fusion proteins and predicted
 sheets with similarities to the b and c  sheets of TBEV
E are indeed predicted to be present on either side of the
putative HCV E1 fusion peptide by Chou-Fasman and Rob-
son-Garnier analysis. HCV E1 also has an extended region
of similarity with the amino acid sequence between the two
longest helices in TBEV E, A and B. There is a statisti-
cally significant (P  0.025) alignment of aa 316–356 of
HCV E1 with aa 496–544 of TBEV E (Fig. 1B).
To determine the plausibility of these alignments, a
three-dimensional model of HCV E1 was scaffolded on
domain II of TBEV E (Fig. 2A). Similar sequences/struc-
tures were drawn in similar locations. Reorienting the “b”
sheet in E1 is the only change relative to E required to bring
the eight cysteine residues into close proximity. The four
dicysteines of HCV E1 potentially form a “zipper” down the
center of the molecule like the three dicysteines in domain
II of TBEV E (Fig. 2B). This model locates the five HCV
E1 glycosylation sites so they are surface accessible. Addi-
tionally, most of the hydrophobic residues are present in a
region on one side of E1 between the fusion peptide and the
transmembrane anchor (see below, Fig. 5). Collectively,
these results suggest that HCV E1 is a truncated class II
fusion protein.
Each of the HCV E1 structures drawn in Fig. 2B con-
forms to both Chou-Fasman and Robson-Garnier predic-
tions, with the exception of the region from “i” to “B.” The
structures designated “i” and “j” were predicted to be 
sheets by Chou-Fasman analysis, but  helical by Robson-
Fig. 1. Alignments of tick-borne encephalitis virus E, hepatitis C virus E1, and classical swine fever virus E2. Panel A: Alignments were constructed as
detailed in the text. Amino acids are numbered from the beginning of the TBEV, HCV and CSFV polyproteins in this and subsequent figures. Bracketed HCV
insert sequences are wrapped and do not represent an alignment comparison. (:) refers to identical amino acids. (.) refers to chemically similar amino acids.
Panel B: Linear arrangement of the domain structure of TBEV E as determined by Rey et al. (1995). Regions of significant sequence similarities to TBEV
E in HCV E1 and E2 and CSFV E2 as determined by the PRSS3 sequence alignment program are indicated. Probabilities (P values) are based on 1000
shuffles.
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Garnier analysis. The structure designated “B” was pre-
dicted to be a  sheet by Chou-Fasman analysis, but 
helical by Robson-Garnier analysis. HCV E1 appears to be
missing, relative to TBEV E, much of the portion of the
molecule prior to the transmembrane helix (pre-anchor).
This region of TBEV E follows the trypsin cleavage site at
aa 395 used to generate that portion of the ectodomain of E
examined by X-ray crystallography, and therefore, the
TBEV E pre-anchor (stem) structure is uncertain. The pre-
anchor of TBEV E has been predicted to form amphipathic
 helices (Allison et al., 1999). A sequence (aa 693–721) of
the pre-anchor domain in TBEV E has the characteristics of
a leucine zipper, ie, leucine or other hydrophobic aa in the
first and fourth (a and d) positions of a seven aa periodicity
(Fig. 1A). The pre-anchor sequence of HCV E1 was also
predicted to be an  helix with characteristics of a “leucine
zipper” (Charloteaux et al., 2002). Because of the significant
aa sequence similarity with TBEV E, the HCV E1 second-
ary structures between “A” and “B” were depicted as in
TBEV E. There are several possible alternatives to the 3D
model of HCV E1 drawn in Fig. 2B, and it is possible that
the secondary structures change on interaction with mem-
branes.
In contrast to HCV E1, our analyses did not reveal any
sequences of HCV E2 with significant similarity to any
sequence in domains I or II of TBEV E or any other
flavivirus E protein (representatives of each of the four
major serogroups were examined). Most of the N-terminal
half of HCV E2, which include hypervariable region 1
(HVR 1), is without any sequence similarity to TBEV E.
However, we detected a significant alignment (P  0.025)
of the C-terminal half of HCV E2 (aa 549–726) with the
region of TBEV E (aa 590–763) from domain III through
the first of two predicted transmembrane spanning domains
of TBEV E (Fig. 1, TBEV E TM1, aa 448–469, TMpred:
1496; TM2, aa 474–496, TMpred: 1962). As discussed
above, the pre-anchor region of TBEV E has a sequence (aa
693–721) with features of a leucine zipper; a similar motif
(aa 675–703) is found in the HCV E2 pre-anchor (Fig. 1). in
addition, the carboxyl (C) terminus of HCV E2, like that of
TBEV E, contains a stretch of hydrophobic amino acids that
potentially could span the membrane twice. The transmem-
brane anchor(s) of HCV E2 (TMpred score: 1364) is inter-
rupted by charged amino acids like TM1 of TBEV E. Thus,
by sequence alignments and structural predictions there are
demonstrable similarities between the C-terminal portions
of HCV E2 and TBEV E.
Proteomic computational analysis suggests that pestivirus
E2 is a truncated class II fusion protein
To provide additional evidence for the HCV E1 class II
fusion protein model, we determined whether the fusion
proteins of the third Flaviviridae genus, pestiviruses, might
share structural/sequential similarities with fusion proteins
of members of the flavivirus and hepacivirus genuses. Pes-
tiviruses encode three envelope glycoproteins, Erns, E1 and
E2. Erns, a secreted protein with RNAse activity, does not
have a hydrophobic transmembrane anchor domain. Erns
does possess a C-terminal charged amphipathic segment
that can mediate translocation of Erns across bilayer mem-
branes (Langedijk, 2002). Pestivirus E1 and E2 both have
C-terminal hydrophobic domains that could function as
transmembrane anchors. Therefore, we postulated that ei-
ther pestivirus E1 or E2 must be the pestivirus fusion pro-
tein.
A putative fusion peptide (aa 818–828) is present in
CSFV E2, containing a consensus sequence with aromatic
and hydrophobic aa located between two cysteine residues
(Fig. 1). The cysteine residues as well as the sequences in
between are highly conserved among pestiviruses, as is true
of fusion peptides from other enveloped RNA viruses of
class I and II (not shown). Although statistically significant
alignments were not detected between the N-terminus of
CSFV E2 and TBEV E (or between other flaviviruses), a
significant alignment (P  0.01) was detected between
CSFV E2 (aa 792–835) and HCV E1 (aa 253–294) in this
region (Fig. 1B). Furthermore, sequences flanking the pu-
tative fusion peptide were predicted to form  sheets by
both Chou-Fasman and Robson-Garnier analyses (supple-
mental data). A significant alignment (P  0.05) between
CSFV E2 (aa 841–913) and HCV E1 (aa 301–383) was also
determined. By extension, the central portion of CSFV E2 is
predicted to structurally resemble domain II of TBEV E. A
significant alignment (P  0.005) was detected between aa
914–1018 of CSFV E2 and a sequence in domain III of
TBEV E (aa 587–685) (Fig. 1B). There was also a signif-
icant similarity (P  0.005) of this region of CSFV E2 (aa
914–1123) with a sequence (aa 549–743) in the region of
HCV E2 that aligns with TBEV domain III. In addition,
TMpred confirmed that the hydrophobic C-terminal domain
of CSFV E2 has a high propensity to span the lipid bilayer
(score: 1137). Like the transmembrane domains of HCV
E1/E2 and TBEV TM1, the putative transmembrane anchor
of CSFV E2 has a central positive charge.
On the basis of the regions of significant sequence sim-
Fig. 2. Models of hepacivirus E1 and pestivirus E2 based of the structure of tick-borne encephalitis virus E. Panel A. Structure of TBEV E as determined
by Rey et al. (1995) is shown schematically (traced from a RasMac rendering). Panel B: A model fitting HCV E1 to the structure of TBEV E. HCV E1
sequences with similarity to TBEV E sequences are enclosed in quotation marks. Panel C: A model fitting CSFV E2 to the structure of TBEV E. TBEV E
domains I–III are colored green, yellow/orange, blue, respectively, with the fusion peptide red. Similar structures are color-coded the same way in HCV E1
and CSFV E2. Black lines: dicysteine linkages. Plum amino acids or black stick figures: glycosylation sites (underlined site with central proline often not
be used). Black and white structures were predicted as described in the text. A black stripe indicates a “leucine zipper.” Violet: transmembrane domains. Blue
amino acids: positively charged.
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ilarities between CSFV E2, HCV E1/E2 and TBEV E,
coupled with the internal location of a possible fusion pep-
tide, we conclude that relative to TBEV E, CSFV E2 is
lacking a portion of domain I including segments corre-
sponding to  sheets Eo through Io. CSFV E2 also appears
to contain a somewhat shorter segment relative to TBEV E
in the pre-anchor domain, ie, the sequence between the
alignment with TBEV E domain III and the transmembrane
domain (Fig. 1B). No leucine zipper is evident in the pre-
anchor of CSFV E2. A three dimensional model of CSFV
E2 (Fig. 2C) confirms that the alignment in Fig. 1 is plau-
sible. Each of the cysteine residues is in proximity to other
cysteine residues and potentially form dicysteine bridges.
Like HCV E1, CSFV E2 conforms to the structure of a
truncated class II fusion protein, albeit with fewer trunca-
tions relative to flavivirus E than HCV E1. Because E1 is
conserved among the pestivirus genus, the similarities of
CSFV E2 with TBEV E extend to other pestiviruses.
None of the E1 envelope glycoproteins of any pestivirus
bear any significant sequence similarities to any sequenced
flavivirus E protein. Immature flavivirus virions contain a
precursor prM to the small membrane protein M. prM is
cleaved in the endoplasmic reticulum by furin or by a
furin-like protease during virus release to produce the ma-
ture M protein localized on the surface of flavivirus virions
(Stadler et al., 1997). A sequence (aa 173–256) of CSFV E1
has similarity (P  0.030) to aa 583–654 of TBEV prM
(Fig. 3A). CSFV E1 does not contain the sequence RXR/
KR, the furin consensus cleavage site. CSFV E1 also does
not contain an identifiable fusion peptide, although TMpred
predicts a significant transmembrane spanning domain in
the first third of CSFV E1. Like the transmembrane domains
of TBEV E, HCV E1 and E2 and CSFV E2, and TBEV prM
(TMpred score  1828), the C-terminus of CSFV E1 is
predicted to form a membrane spanning domain (TMpred
score  1884) with a central positive charge.
Gene order of Flaviviridae genomes
Genes that encode proteins with similar functions may be
present in similar locations in genomes of different mem-
bers of the Flaviviridae family. The positive-polarity single-
stranded RNA genomes of all members of the Flaviviridae
are translated into a single large polyprotein that is subse-
quently cleaved by viral and cellular proteases into func-
tional proteins. The order (from N to C terminus) of proteins
in the polyproteins of TBEV and other members of the
flavivirus genus is C-prM-E-nonstructurals (C: capsid), and
the order of proteins in the polyproteins of hepaciviruses is
C-E1-E2-p7-nonstructurals (Fig. 4). The 5 portion of the
flavivirus E gene encodes the fusion peptide in domain II of
Fig. 3. Alignments of the precursor of tick-borne encephalitis virus small membrane protein, prM, and classical swine fever virus E1. Panel A: alignments
were constructed as detailed in the text. Panel B: Linear arrangement of TBEV prM and CSFV E1 with a region of sequence similarity determined by the
PPSS3 algorithm indicted.
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the E protein, whereas the receptor binding domain of E is
probably located in domain III encoded by the 3 portion of
the E gene (Crill and Roehrig, 2001; Mandl et al., 2000).
Fusion and receptor functions may reside in two different
HCV proteins, E1 and E2 respectively, occurring in the
same order as the domains of flavivirus E that carry out
these functions (Fig. 4). Hepacivirus E1 and E2 may have
arisen by insertion of a transmembrane anchor and variable
domains, including hypervariable region 1 (HVR-1, Fig. 1),
into the ancestral E gene. Alternatively, HCV E1 could have
evolved into a separate fusion protein from an ancestral
prM, with concurrent loss of the fusion peptide and fusion
functions in E2. The sequence similarities between TBEV E
and HCV E1 and E2, however, do not favor this latter
possibility.
The order of proteins in pestivirus polyproteins is Npro-
C-Erns-E1-E2-p7-nonstructurals. Pestiviruses encode two
proteins, Npro and Erns, with no obvious homologs among
members of the other two Flaviviridae genuses. Pestivirus
E1 and E2 are similar in sequence to flavivirus M and E,
respectively. Like TBEV E, pestivirus E2 may serve both as
fusion protein and receptor binding protein. These functions
are carried out by TBEV E domains II and III that appear to
be represented by similar structures in pestivirus E2 (Fig. 4).
TBEV PrM/M functions to protect internal cellular mem-
branes from fusion mediated by E2, and it is possible that
pestivirus E1 serves the same function for E2, the fusion/
receptor protein. Excepting Npro and Erns, the order of
structural proteins with sequence and other similarities is
analogous in pestiviruses and flavivirus polyproteins.
TBEV E has two hydrophobic C-terminal transmem-
brane domains, TM1 and TM2 (Fig. 1). Hepaciviruses and
pestiviruses encode a small hydrophobic peptide, p7, which
could associate with cellular or viral membranes. The cleav-
age that produces p7 is inefficient and delayed, and there-
fore much of HCV E2 and pestivirus E2 are present in the
cell as uncleaved E2-p7 precursors (Harada et al., 2000).
The p7 gene is located in a similar genomic location and
could have evolved from the sequence encoding the second
transmembrane domain, TM2, of flavivirus E (Fig. 4). The
consensus Flaviviridae genome can therefore be represented
as X1-C-X2-M-fusion-binding-TM1-TM2-nonstructurals-
3, where X 1 and X2 represents inserted sequences in
pestiviruses, Npro and Erns, respectively, M represents fla-
vivirus prM/M-pestivirus E1, and TM2 is the second trans-
membrane domain of flaviviruses and p7 of hepaciviruses
and pestiviruses. These similarities in gene order and func-
tions support the hypothesis that HCV E1 is the fusion
protein of HCV.
Membrane interfacial domains in a class I fusion protein
and HCV E1
Although the overall structures of class I and II fusion
proteins are distinct, they may share structural/functional
characteristics in the parts of the molecules that interact
with and disrupt bilayer membranes. It is well established
that class I fusion proteins have a fusion peptide at the
amino terminus of the molecule that is critical for fusion
(Gallaher, 1987, 1996; Gallaher et al., 1989, 2001). Class II
fusion proteins have an internal fusion peptide that are
located after secondary structural folding at distal locations
from the transmembrane anchor (Kuhn et al., 2002; Lescar
Fig. 4. Common order of proteins in Flaviviridae polyproteins. Proteins or portions of proteins with similar functions are located in similar locations along
the polyproteins of members of the Flaviviridae. Hydrophobic domains were predicted using TMpred.
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et al., 2001; Rey et al., 1995). To provide further support for
the proposed models of HCV E1 and pestivirus E2, we used
another proteomics computational tool to compare other
potential membrane interactive domains in the proteins with
the HIV-1 transmembrane glycoprotein (TM), a class I
fusion protein. Besides fusion peptides, another motif in
class I fusion proteins that can be important in virus:cell
fusion is an aromatic as rich motif proximal to the anchor
(Fig. 5A, aa 667–683, green) (Suarez et al., 2000). The
pre-anchor domains of class I fusion proteins are not highly
hydrophobic according to the Kyte-Doolittle hydropathy
prediction algorithm; however, these domains have a ten-
dency to partition into bilayer membranes, as revealed by
analyses using the Wimley-White interfacial hydrophobic-
ity scale (Suarez et al., 2000; Wimley and White, 1996).
HCV E1 contains three domains that produce significant
Wimley-White partition scores using Membrane Protein
eXplorer (Jaysinghe et al., 2000). One of these is the trans-
membrane anchor (aa 361–372). The other two sequences
with significant Wimley-White partition scores are located
immediately following the fusion peptide (aa 284–300) and
at a location (aa 321–340) that the model in Figure 2B
predicts to be near the bilayer membrane (Fig. 5B, green).
These two HCV E1 domains, in conjunction with the fusion
peptide and the transmembrane anchor, potentially form a
continuous track of membrane interactive regions that could
channel the movement of lipids during virion:cell fusion.
These Wimley-White partition analyses thus provide addi-
tional support for the proposal that E1 is the fusion protein
of HCV.
Discussion
The use of proteomics computational tools, including aa
sequence alignments and algorithms that predict protein
Fig. 5. Comparison of human immunodeficiency virus transmembrane glycoprotein (TM with hepatitis C virus envelope glycoprotein 1 (E1). Panel A: an
updated model of HIV-1 TM from Gallaher et al. (1989) with structural motifs indicated in rainbow order. Amino acids are numbered from the beginning
of the Env polyprotein. HIV-1 TM is truncated after the transmembrane domain. The precise ends of the TM N- and C-helices are unclear because of
conflicting structural data. No attempt was made to align the N- and C-helices, although points of contact are solved in the coiled-coil formations. Positions
of known neutralizing epitopes on TM are indicated, as well as sequences corresponding to peptides CS3 and DP178 (T20) (Qureshi et al., 1990; Wild et
al., 1994) that inhibit HIV-1 infectivity. Panel B: model of HCV E1 with motifs that are shared with HIV-1 TM. Boxed arrows are predicted beta sheet
structures; those colored yellow are similar to the indicated  sheets of TBEV E. Predicted alpha helical structures are outlined. Arrows denote directions
that the HCV E1 structure could fold in three dimensions.
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structure/function, suggests that the ectodomain of HCV E1
is a truncated version of the class II fusion protein structure
first determined by Rey et al. (1995) for TBEV E. The
ectodomain of HCV E1 is roughly equivalent to the part of
TBEV E from the “hinge” region to the fusion peptide (Fig.
2). E2 envelope glycoproteins of pestiviruses also exhibited
local sequence similarities and other predicted structures
similar to TBEV E and HCV E1, allowing the determination
that pestivirus E2 proteins are also likely to be truncated
class II fusion proteins, although with fewer truncations
relative to TBEV E than HCV E1. Significant alignments of
E1 of hepatitis GB virus (GBV-B) with HCV E1 suggest
that this unclassified member of the Flaviviridae family also
encodes a truncated class II fusion protein (not shown).
Our conclusions contrast with those of Yagnik et al.
(2000), who predicted that HCV E2 fits the scaffold of a
complete class II fusion protein. HCV E1 contains a fusion
peptide (Flint et al., 1999), a required motif in both class I
and II fusion proteins, but HCV E2 has no amino acid
sequence that is likely to function as a fusion peptide. The
sequence predicted by Yagnik et al. (2000) to occupy the
end of E2 most distal from the transmembrane domain,
which is the location of other class II fusion peptides, does
not contain a fusion peptide motif. Class I fusion proteins
are generally more highly conserved among strains of a
given virus than the corresponding receptor protein. The
most variable domain of the two HCV envelope proteins,
HVR-1, is located in E2 (Fig. 1) (Weiner et al., 1991). The
placement of the cysteine residues also fails to support the
model proposed by Yagnik and co-workers because the
cysteines are spaced such that it would be difficult to form
disulfide linkages. Our results do suggest that there are
sequence and structural similarities between HCV E2 and
TBEV E. However, these similarities are limited to the
C-terminal portions of these proteins, and our alignments
are different that those proposed previously (Yagnik et al.,
2000).
Hepaciviruses, like alphaviruses, appear to use one en-
velope protein for attachment (E2) and another for fusion
(E1). In contrast, E glycoproteins of TBEV, dengue virus,
and other members of the flavivirus genus mediate both
receptor binding and membrane fusion functions. E2 func-
tions as one of the pestivirus receptor-binding proteins
(Hulst and Moormann, 1997), and if the current analysis is
correct, also carries out the virion:cell fusion function. In
addition to E, flaviviruses encode a membrane protein prM
whose functions may include shielding of cellular mem-
branes from the fusion peptide of E (Kuhn et al., 2002).
Functions of the flavivirus small membrane protein may be
vested in E1 of pestiviruses, which has significant sequence
similarity with flavivirus prM. Mature flavivirus virions
contain prM that has been cleaved to M. Unlike M, pesti-
virus E1 does not associate with the virion envelope as a
precursor protein and lacks a furin cleavage site.
HCV E1 may represent the minimal class II fusion pro-
tein structure required to mediate virion:cell fusion. Cell
entry of flaviviruses and togaviruses that encode class II
fusion proteins occurs via the endocytic route, where expo-
sure to low pH may trigger several conformational changes
in the envelope proteins and in the virion itself. In the case
of TBEV and dengue virus, E converts from a dimer to a
trimer bending upward to expose the fusion peptide. The 
sheets of E may also rearrange to form a closed  barrel that
can insert into the vesicular membrane in the manner of
porins, a family of bacterial toxins. Similar changes proba-
bly occur during SFV entry, except that exposure of the
fusion peptide on E1 may depend on a pH-induced confor-
mational change in envelope protein, E2 (Lescar et al.,
2001). A variation on this model posits that the pH change
permits bending of the class II fusion proteins at the flexible
“hinge” region between domains I and II, elevating the
fusion peptide so that it can insert into the host membrane
(Fig. 2A) (Lescar et al., 2001). Class II fusion proteins may
even adapt a “snap-back” configuration, as proposed for
class I fusion proteins, in which the fusion peptide moves
closer to domain III, bringing the virus and cell membranes
into contact and providing energy to drive the fusion reac-
tion. HCV E1 and perhaps pestivirus E2 may not require
these latter rearrangements. Instead, energy for driving
membrane fusion may be derived from a shift from an open
to a closed  barrel. Energy for the fusion reaction may also
be derived from increasing favorable protein:lipid interac-
tions, or from multimerization of the proteins into a ring
surrounding the fusion pore as occurs with the upright spike
glycoprotein (G) of rhabdoviruses (Carneiro et al., 2002;
Roche and Gaudin, 2002).
The models proposed here are supported by the obser-
vations that envelope glycoproteins with significant se-
quence similarities (HCV E1/2, TBEV E and pestivirus E2,
and TBEV prM and pestivirus E1) are in analogous loca-
tions in the polyproteins encoded by the three genuses of the
Flaviviridae. These results suggest that members of the
Flavivirus family may have a common ancestor. Divergence
of the genes for the fusion proteins within the three genuses
of this family may have occurred either through acquisition
of sequences and/or lose of sequences in a cassette manner
constrained by the domain organization of class II fusion
proteins.
While the proteomic computational tools employed here
have a good predictive value, X-ray crystallography will be
required to determine whether HCV E1/E2 or pestivirus E2
have any structural similarities to class II fusion proteins.
Development of a cell culture system that produces useful
quantities of HCV particles is a prerequisite to defining the
arrangement of the envelope glycoproteins on the virion
surface as has been done for flaviviruses and togaviruses
(Kuhn et al., 2002; Lescar et al., 2001). Diffractable crystals
of HCV E1 or E2 and highly productive systems for HCV
propagation are not currently available. In this regard, better
drugs to treat HCV infection and an effective vaccine to
prevent HCV infection are urgently needed. In the United
States alone an estimated 4 million people are already in-
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fected by HCV, four times the number infected by HIV-1.
HCV is an important cause of liver failure and hepatocel-
lular carcinoma. A substantial portion of HCV-infected in-
dividuals show little or no response to treatment with inter-
ferons and/or ribovirin, the only approved therapeutics.
Models such as proposed here can provide useful hypothe-
ses to guide experimental strategies for development of
vaccines or drugs to prevent or treat HCV infection. Prior to
the availability of X-ray structural data (Wild et al., 1993;
Wild et al., 1994), several potent HIV-1 TM inhibitors were
developed based on the Gallaher HIV-1 TM fusion protein
model (Gallaher et al., 1989). DP178 (T20) peptide (Fig.
5A) has been shown to substantially reduce HIV-1 load in
AIDS patients in preliminary results from phase III clinical
trials (Hoffman-La Roche and Trimeris, 2002). Analogous
peptides may be designed to block HCV virion:cell fusion.
Drug and vaccine strategies targeted to the HCV envelope
proteins may be broadly applicable to other members of the
Flaviviridae.
Materials and methods
Sequences
Prototype strains of representatives of the three Flaviviri-
dae genuses were used for sequence and structural compar-
isons. The strains examined include TBEV strain Neudoerfl
(accession number: P14336), human prototype strain H
(subtype 1a) of hepatitis C virus (P27958), and the Alfort
187 strain of classical swine fever virus, also known as hog
cholera virus (CAA61161). Some comparisons used repre-
sentatives of the major serogroups of flaviviruses, including
Japanese encephalitis virus, strain JaOARS982 (P32886),
yellow fever virus, strain 17D-204 (PI9901), dengue virus
type 2, strain PR-159/S1 (P12823), and West Nile virus,
strain NY 2000-crow3356 (AF404756). Type species of
other pestiviruses, including bovine viral diarrhea virus
(BVDV) genotype 1 aka pestivirus type 1, stain NADL
(CAB91847), and border disease virus strain BD31
(AAB37578), were used in other comparisons. We also
compared HCV sequences to those of GB virus–B virus
(AAC54059), an unassigned member of the Flaviviridae.
Proteomics computational methods
Methods to derive general models of surface glycopro-
teins have been described previously (Gallaher et al., 1989).
MacMolly (Soft Gene GmbH, Berlin) was used to locate
areas of limited sequence similarity and to perform Chou-
Fasman and Robson-Garnier analyses. PRSS3, a program
derived from rdf2 (Pearson and Lipman, 1988), which uses
the Smith-Waterman sequence alignment algorithm (Smith
and Waterman, 1981), was used to determine the signifi-
cance of protein alignments. PRSS3 is part of the FASTA
package of sequence analysis programs available by anon-
ymous ftp from ftp.virginia.edu. Default settings for PRSS3
were used, including the blosum50 scoring matrix, gap
opening penalty of 12, and gap extension penalty of 2. The
alignments presented are those that produced the highest
alignment scores, rather than the longest sequences that
produced significant scores. Chou-Fasman and Robson-
Garnier algorithms predict protein structures in an aqueous
environment, but they cannot predict protein structures in a
lipid bilayer. Domains with significant propensity to form
transmembrane helices were identified with TMpred
(ExPASy, Swiss Institute of Bioinformatics). TMpred is
based on a statistical analysis of TMbase, a database of
naturally occurring transmembrane glycoproteins (Hofmann
and Stoffel, 1993). Sequences with a propensity to partition
into the lipid bilayer were identified with Membrane Protein
eXplorer from the Stephen White laboratory (Jaysinghe et
al., 2000) using default settings. RasMac, developed by
Roger Sayle, was used to render 3D models of TBEV E.
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